Abstract
The increasing global threat of multi drug resistant pathogens is indicating that this is the time to put together our efforts to develop some approaches to turn down the spread of drug resistivity among the microbial world. The best way to reduce the evolution of antimicrobial resistance is to eliminate the heavy burden of antibiotics from our environment. The unfeasibility of elimination of antibiotics from our healthcare system directs us to develop some effective means to reduce their use at the least level. For this, we need to shift from completely antibiotic dependent therapeutic strategy to the multiple prophylactic and therapeutic approaches. Substantial efforts are being invested worldwide to find the sustainable line of defense against the rising pressure of antimicrobial resistance.
In this chapter we investigated the possible role of alternative multiple strategies using biologics such as probiotics, prebiotics, synbiotics and their metabolites in alleviation of the development of drug resistance. These environment and host friendly approaches could reduce the burden of infections by the means of direct or indirect mechanisms such as colonization interference, antimicrobial activity and stimulation of host defense system. Regardless of prompt research and substantial increase in clinical relevance, the approaches are still used as subsidiary or prophylactic strategy only. Advanced efforts are required to establish them as an absolute therapeutic alternative to reduce or replace the use of antibiotics.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdelhamid AG, Esaam A, Hazaa MM (2018) Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli. Saudi Pharm J 26:603–607. https://doi.org/10.1016/j.jsps.2018.03.004
Abdhul K, Ganesh M, Shanmughapriya S, Vanithamani S, Kanagavel M, Anbarasu K et al (2015) Bacteriocinogenic potential of a probiotic strain Bacillus coagulans [BDU3] from Ngari. Int J Biol Macromol 79:800–806
Agheli N, Kabir M, Berni-Canani S, Petitjean E, Boussairi A, Luo J, Bornet F, Slama G, Rizkalla SW (1998) Plasma lipids and fatty acid synthase activity are regulated by short-chain fructo-oligosaccharides in sucrose-fed insulin-resistant rats. J Nutr 128(8):1283–1288. https://doi.org/10.1093/jn/128.8.1283
Amrouche T, Boutin Y, Priouit G, Fliss I (2006) Effects of bifidobacterial cytoplasm, cell wall and exopoly saccarides on mouse lymphocytes proliferation and cytokine production. Int Dairy J 16:70–80
Anderson RC, Cookson AL, McNabb WC, Park Z, McCann MJ, Kelly WJ, Roy NC (2010) Lactobacillus plantarum MB452 enhances the function of the intestinal barrier by increasing the expression levels of genes involved in tight junction formation. BMC Microbiol 10:316. https://doi.org/10.1186/1471-2180-10-316
Ankolekar C, Pinto M, Greene D, Shetty K (2011) Phenolic bioactive modulation by Lactobacillus acidophilus mediated fermentation of cherry extracts for anti-diabetic functionality, Helicobacter pylori inhibition and probiotic Bifidobacterium longum stimulation. Food Biotechnol 25(4):305–335. https://doi.org/10.1080/08905436.2011.617255
Ayeni FA, Adeniyi BA, Ogunbanwo ST, Tabasco R, Paarup T, Peláez C et al (2009) Inhibition of uropathogens by lactic acid bacteria isolated from dairy foods and cow’s intestine in western Nigeria. Arch Microbiol 191(8):639–648. https://doi.org/10.1007/s00203-009-0492-9
Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ (2006) Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 72:3593–3599. https://doi.org/10.1128/AEM.72.5.3593-3599.2006
Bermudez-Brito M, Plaza-Diaz J, Munoz-Quezada S, Gomez-Llorente C, Gil A (2011) Probiotic mechanisms of action. Ann Nutr Metab 61:160–174. https://doi.org/10.1159/000342079
Bhushan B, Singh BP, Saini K, Kumari M, Tomar SK, Mishra V (2019) Role of microbes, metabolites and effector compounds in host–microbiota interaction: a pharmacological outlook. Environ Chem Lett 1:1–20. https://doi.org/10.1007/s10311-019-00914-9
Biswas A, Messam R, Kumawat M, Namit M, Mandal AB, Mir NA (2018) Effects of prebiotics on intestinal histo-morphometry and gut microflora status of broiler chickens. Indian J Anim Res 8:1–5. https://doi.org/10.18805/ijar.B-3579
Bodera P (2008) Influence of prebiotics on the human immune system (GALT). Recent Patents Inflamm Allergy Drug Discov 2(2):149–153. https://doi.org/10.2174/187221308784543656
Caballero-Franco C, Keller K, De Simone C, Chadee K (2007) The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 292:G315–G322. https://doi.org/10.1152/ajpgi.00265.2006
Carlson BA, Nightingale KK, Mason GL, Ruby JR, Choat WT, Loneragan GH, Smith GC, Sofos JN, Belk KE (2009) Escherichia coli O157: H7 strains that persist in feedlot cattle are genetically related and demonstrate an enhanced ability to adhere to intestinal epithelial cells. Appl Environ Microbiol 75:5927–5937. https://doi.org/10.1128/AEM.00972-09
Charteris W, Phillip MK, Morelli L, Collins JK (1998) Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot 61:1636–1643. https://doi.org/10.4315/0362-028x-61.12.1636
Chen H, Hoover DG (2003) Bacteriocins and their food applications. Compr Rev Food Sci Food Saf 2(3):82–100. https://doi.org/10.1080/10408398.2015.1020918
Connolly ML, Lovegrove JA, Tuohy KM (2010) Konjac glucomannan hydrolysate beneficially modulates bacterial composition and activity within the faecal microbiota. J Funct Foods 2(3):219–224. https://doi.org/10.1016/j.jff.2010.05.001
Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, Foster S, Gilmore BF, Hancock RE, Harper D, Henderson IR (2016) Alternatives to antibiotics—a pipeline portfolio review. Lancet Infect Dis 16(2):239–251. https://doi.org/10.1016/S1473-3099(15)00466-1
Czerucka D, Piche T, Rampal P (2007) Yeast as probiotics—Saccharomyces boulardii. Aliment Pharmacol Ther 26(6):767–778. https://doi.org/10.1111/j.1365-2036.2007.03442.x
Da Silva S, Robbe-Masselot C, Ait-Belgnaoui A, Mancuso A, Mercade-Loubière M, Salvador-Cartier C, Gillet M, Ferrier L, Loubière P, Dague E, Theodorou V, Mercier-Bonin M (2014) Stress disrupts intestinal mucus barrier in rats via mucin O-glycosylation shift: prevention by a probiotic treatment. Am J Physiol Gastrointest Liver Physiol 307:G420–G429. https://doi.org/10.1152/ajpgi.00290.2013
Daddaoua A, Martínez-Plata E, López-Posadas R, Vieites JM, González M, Requena P, Zarzuelo A, Suarez MD, de Medina FS, Martinez-Augustin O (2007) Active hexose correlated compound acts as a prebiotic and is anti-inflammatory in rats with hapten-induced colitis. J Nutr 137(5):1222–1228. https://doi.org/10.1093/jn/137.5.1222
Dalmasso G, Loubat A, Dahan S, Calle G, Rampal P, Czerucka D (2006) Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157:456–465. https://doi.org/10.1016/j.resmic.2005.11.007
Daubioul C, Rousseau N, Demeure R, Gallez B, Taper H, Declerck B, Delzenne N (2002) Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J Nutr 132:967–973. https://doi.org/10.1093/jn/132.5.967
Dbouk N, McGuire BM (2006) Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Opt Gastroenterol 9:464–474. https://doi.org/10.1007/s11938-006-0003-x
De Vuyst L, Foulquie-Moreno MR, Revets H (2003) Screening for enterocins and detection of hemolysin and vancomycin resistance in enterococci of different origins. Int J Food Microbiol 84:299–318. https://doi.org/10.1016/s0168-1605(02)00425-7
de Waard R, Garssen J, Snel J, Bokken GC, Sako T, Veld JH, Vos JG (2001) Enhanced antigen-specific delayed-type hypersensitivity and immunoglobulin G2b responses after oral administration of viable Lactobacillus casei YIT9029 in Wistar and Brown Norway rats. Clin Diagn Lab Immunol 8:762–767. https://doi.org/10.1128/CDLI.8.4.762-767.2001
Delzenne NM, Kok N, Fiordaliso MF, Deboyser DM, Goethals FM, Roberfroid MB (1993) Dietary fructooligosaccharides modify lipid metabolism in rats. Am J Clin Nutr 57:820S. https://doi.org/10.1093/ajcn/57.5.820S
Doenyas C (2018) Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder. Neuroscience 374:271–286. https://doi.org/10.1016/j.neuroscience.2018.01.060
Ducatelle R, Eeckhaut V, Haesebrouck F, Van Immerseel F (2015) A review on prebiotics and probiotics for the control of dysbiosis: present status and future perspectives. Animal 9:43–48. https://doi.org/10.1017/S1751731114002584
EL-Deib SM, Abd Rabo FHR, Badran SM, Abd El-Fattah AM, Elshaghabee FMF (2012) The growth behavior and enhancement of probiotic viability in bio-yoghurt. Int Dairy J 22:44. https://doi.org/10.1016/j.idairyj.2011.08.003
El-Shafei K, Elshaghabee FMF, El-Sayed HS, Kassem JM (2018) Assessment the viability properties of Lactobacillus casei strain using Labneh as a carrier. Acta Sci Pol Technol Aliment 17(3):267–276. https://doi.org/10.17306/J.AFS.0583
Elshaghabee FMF, Rokana N, Gulhane R, Sharma C, Panwer H (2017) Bacillus as potential probiotics: status, concerns, and future perspectives. Front Microbiol 10:1490. https://doi.org/10.3389/fmicb.2017.01490
Elshaghabee FM, Rokana N, Panwar H, Heller KJ, Schrezenmeir J (2019) Probiotics for dietary management of non-alcoholic fatty liver disease. Environ Chem Lett 1:1–1. https://doi.org/10.1007/s10311-019-00896-8
Esaiassen E, Hjerde E, Cavanagh JP, Pedersen T, Andresen JH, Rettedal SI, Støen R, Nakstad B, Willassen NP, Klingenberg CA (2018) Effect of probiotic supplementation on the gut microbiota and antibiotic resistome development in preterm infants. Front Pediatr 6:347. https://doi.org/10.3389/fped.2018.00347
Evans M, Salewski RP, Christman MC, Girard SA, Tompkins TA (2016) Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial. Br J Nutr 116(1):94–103. https://doi.org/10.1017/S0007114516001665
Evrard B, Coudeyras S, Dosgilbert A, Charbonnel N, Alamé J, Tridon A, Forestier C (2011) Dose-dependent immunomodulation of human dendritic cells by the probiotic Lactobacillus rhamnosus Lcr35. PLoS One 6(4):e18735. https://doi.org/10.1371/journal.pone.0018735
Figueroa-González I, Quijano G, Ramírez G, Cruz-Guerrero A (2011) Probiotics and prebiotics - perspectives and challenges. J Sci Food Agric 91(8):1341–1348. https://doi.org/10.1002/jsfa.4367
Franz CM, Muscholl-Silberhorn AB, Yousif NM, Vancanneyt M, Swings J, Holzapfel WH (2001) Incidence of virulence factors and antibiotic resistance among enterococci isolated from food. Appl Environ Microbiol 67:4385–4389. https://doi.org/10.1128/AEM.67.9.4385-4389.2001
Froy O (2005) Regulation of mammalian defense in expression by Toll-like receptor-dependent and independent signalling pathways. Cell Microbiol 7:1387–1397. https://doi.org/10.1111/j.1462-5822.2005.00590.x
Gao R, Zhang X, Huang L, Shen R, Qin H (2019) Gut microbiota alteration after long-term consumption of probiotics in the elderly. Probiotics Antimicrob Proteins 11:655–667. https://doi.org/10.1007/s12602-018-9403-1
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412. https://doi.org/10.1093/jn/125.6.1401
Gibson GR, Roberfroid MB (1999) Prebiotics. In: Colonic microbiota, nutrition and health. Kluwer Academic, Dordrecht, pp 101–124. https://doi.org/10.1007/978-94-017-1079-4
Gillor O, Etion A, Riley MA (2008) The dual role of bacteriocins as anti- and probiotics. Appl Microbiol Biotechnol 81(4):591–606. https://doi.org/10.1007/s00253-008-1726-5
Gomaa EZ (2018) Synergistic antibacterial efficiency of bacteriocin and silver nanoparticles produced by probiotic Lactobacillus paracasei against multidrug resistant bacteria. Int J Pept Res Ther 2018:1–3. https://doi.org/10.1007/s10989-018-9759-9
Halder D, Mandal S (2016) Antibacterial potentiality of commercially available probiotic lactobacilli and curd lactobacilli strains, alone and in combination, against human pathogenic bacteria. Transl Biomed 7:2. https://doi.org/10.21767/2172-0479.100061
Hammami R, Ben Abdallah N, Barbeau J, Fliss I (2015) Symbiotic maple saps minimize disruption of the mice intestinal microbiota after oral antibiotic administration. Int J Food Sci Nutr 66(6):665–671. https://doi.org/10.3109/09637486.2015.1071340
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al (2014a) Expert consensus document: the International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC (2014b) The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. https://doi.org/10.1038/nrgastro.2014.66
Holscher HD (2017) Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes 8(2):172–184. https://doi.org/10.1080/19490976.2017.1290756
Ibraheem SK, Alshaibani AB, Ad’hiah AH (2014) Protective effect of Lactobacillus acidophilus and Saccharomyces cerevisiae against multi-drug resistant Salmonella enterica serovar typhimurium in vitro and in vivo. World J Pharm Res 3:193–203
Ispirli H, Demirbas F, Dertli E (2017) Characterization of functional properties of Enterococcus spp. Isolated from Turkish white cheese. LWT Food Sci Technol 75:358–368. https://doi.org/10.1016/j.lwt.2016.09.010
Izcue A, Coombes JL, Powrie F (2006) Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol Rev 212:256–271. https://doi.org/10.1111/j.0105-2896.2006.00423.x
Jačan A, Kashofer K, Zenz G, Fröhlich EE, Reichmann F, Hassan AM, Holzer P (2019) Synergistic and antagonistic interactions between antibiotics and synbiotics in modifying the murine fecal microbiome. Eur J Nutr:1–14. https://doi.org/10.1007/s00394-019-02035-z
Jensen GS, Cash HA, Farmer S, Keller D (2017) Inactivated probiotic Bacillus coagulans GBI-30 induces complex immune activating, anti-inflammatory, and regenerative markers in vitro. J Inflamm Res 10:107. https://doi.org/10.2147/JIR.S141660
Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H, Tsuji NM, Kiyono H, Ma JS, Kusu T, Okumura R, Hara H, Yoshida H, Yamamoto M, Nomoto K, Takeda K (2012) Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 8:e1002714. https://doi.org/10.1371/journal.ppat.1002714
Karczewski J, Troost FJ, Konings I, Dekker J, Kleerebezem M, Brummer RJM, Wells JM (2010) Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298:G851–G859. https://doi.org/10.1152/ajpgi.00327.2009
Kaushik JK, Kumar A, Duary RK, Mohanty AK, Grover S, Batish VK (2009) Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One 4(12). https://doi.org/10.1371/journal.pone.0008099
Kogut MH (2013) The gut microbiota and host innate immunity: regulators of host metabolism and metabolic diseases in poultry? J Appl Poult Res 22:637–646. https://doi.org/10.3382/japr.2013-00741
Kondepudi KK, Ambalam P, Nilsson I, Wadstr T (2012) Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile. Anaerobe 18(5):489–497. https://doi.org/10.1016/j.anaerobe.2012.08.005
Kong C, Gao R, Yan X, Huang L, Qin H (2019) Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. Nutrition 60:175–184. https://doi.org/10.1016/j.nut.2018.10.002
Koruri SS, Chowdhury R, Bhattacharya P (2016) Potentiation of functional and antimicrobial activities through synergistic growth of probiotic Pediococcus acidilactici with natural prebiotics (garlic, basil). In: Microbes in the spotlight: recent progress in the understanding of beneficial and harmful microorganisms. BrownWlaker Press, Boca Raton, pp 219–224
Kumar M, Dhaka P, Vijay D, Vergis J, Mohan V, Kumar A, Kurkure NV, Barbuddhe SB, Malik SV, Rawool DB (2016) Antimicrobial effects of Lactobacillus plantarum and Lactobacillus acidophilus against multidrug-resistant enteroaggregative Escherichia coli. Int J Antimicrob Agents 48(3):265–270. https://doi.org/10.1016/j.ijantimicag.2016.05.014
Kwon HK, Lee CG, So JS et al (2010) Generation of regulatory dendritic cells and CD4+Foxp3+T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107:2159–2164. https://doi.org/10.1073/pnas.0904055107
Lebeer S, Vanderleyden J, De Keersmaecker SCJ (2010) Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8:171–184. https://doi.org/10.1038/nrmicro2297
Li J, Wang W, Xu SX et al (2011) Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci U S A 108:3360–3365. https://doi.org/10.1073/pnas.1017431108
Lyons A, O’Mahony D, O’Brien F et al (2010) Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models. Clin Exp Allergy 40:811–819. https://doi.org/10.1111/j.1365-2222.2009.03437.x
Machairas N, Pistiki A, Droggiti DI, Georgitsi M, Pelekanos N, Damoraki G, Kouraklis G, Giamarellos-Bourboulis EJ (2015) Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression. Int J Antimicrob Agents 45(4):376–384. https://doi.org/10.1016/j.ijantimicag.2014.11.013
Madhu AN, Amrutha N, Prapulla SG (2012) Characterization and antioxidant property of probiotic and synbiotic yogurts. Probiotics Antimicrob Proteins 4:90–97. https://doi.org/10.1007/s12602-012-9099-6
Mahmoodpoor A, Hamishehkar H, Asghari R, Abri R, Shadvar K, Sanaie S (2019) Effect of a probiotic preparation on ventilator-associated pneumonia in critically ill patients admitted to the intensive care unit: a prospective double-blind randomized controlled trial. Nutr Clin Pract 34(1):156–162. https://doi.org/10.1002/ncp.10191
Markowiak P, Śliżewska K (2017) Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients 9(9):1021. https://doi.org/10.3390/nu9091021
Mattila-Sandholm T, Matto J, Saarela M (1999) Lactic acid bacteria with health claims-ineractions and interference with gastrointestinal flora. Int Dairy J 9:25–35. https://doi.org/10.1016/S0958-6946(99)00041-2
Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N, Bruewer M (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296:G1140–G1149. https://doi.org/10.1152/ajpgi.90534.2008
Moghadam SS, Khodaii Z, Zadeh SF, Ghooshchian M, Aghmiyuni ZF, Shabestari TM (2018) Synergistic or antagonistic effects of probiotics and antibiotics- alone or in combination- on antimicrobial-resistant Pseudomonas aeruginosa isolated from burn wounds. Arch Clin Infect Dis 13:e63121–e63125. https://doi.org/10.5812/archcid.63121
Mohanta D, Ghangal R, Solanki M, Patnaik S (2020) Delivery of microbial metabolites for human health care: a review. Environ Chem Lett 10:1–9. https://doi.org/10.1007/s10311-020-00967-1
Muñoz-Atienza E, Gómez-Sala B, Araújo C, Campanero C, Del Campo R, Hernández PE et al (2013) Antimicrobial activity, antibiotic susceptibility and virulence factors of lactic acid bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol 13(1):15. https://doi.org/10.1186/1471-2180-13-15
Naderi A, Kasra-Kermanshahi R, Gharavi S, Imani Fooladi AA, Abdollahpour Alitappeh M, Saffarian P (2014) Study of antagonistic effects of Lactobacillus strains as probiotics on multi drug resistant bacteria isolated from urinary tract infections. Iran J Basic Med Sci 17:201–208
Nadimpalli M, Delarocque-Astagneau E, Love DC, Price LB, Huynh BT, Collard JM, Lay KS, Borand L, Ndir A, Walsh TR, Guillemot D (2018) Combating global antibiotic resistance: emerging one health concerns in lower-and middle-income countries. Clin Infect Dis 66(6):963–969. https://doi.org/10.1093/cid/cix879
Nagura T, Hachimura S, Hashiguchi M, Ueda Y, Kanno T, Kikuchi H, Sayama K, Kaminogawa S (2002) Suppressive effect of dietary raffinose on T-helper 2 cell-mediated immunity. Br J Nutr 88:421–427. https://doi.org/10.1079/BJN2002666
Nebot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V (2014) Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol 20:6832–6843. https://doi.org/10.3748/wjg.v20.i22.6832
Ouwehand AC, Forssten S, Hibberd AA, Lyra A, Stahl B (2016) Probiotic approach to prevent antibiotic resistance. Ann Med 48(4):246–255. https://doi.org/10.3109/07853890.2016.1161232
Pandey KR, Naik SR, Vakil BV (2015) Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol 52(12):7577–7587. https://doi.org/10.1007/s13197-015-1921-1
Perdijk O, van Baarlen P, Fernandez-Gutierrez MM, Van Den Brink E, Schuren FH, Brugman S, Savelkoul HF, Kleerebezem M, van Neerven RJ (2019) Sialyllactose and galactooligosaccharides promote epithelial barrier functioning and distinctly modulate microbiota composition and short chain fatty acid production in vitro. Front Immunol 10:94. https://doi.org/10.3389/fimmu.2019.00094
Pérez-Burillo S, Mehta T, Pastoriza S, Kramer DL, Paliy O, Rufián-Henares JÁ (2019) Potential probiotic salami with dietary fiber modulates antioxidant capacity, short chain fatty acid production and gut microbiota community structure. LWT 105:355–362. https://doi.org/10.1016/j.lwt.2019.02.006
Pieterse R, Todorov SD, Dicks LMT (2010) Mode of action and in vitro susceptibility of mastitis pathogens to macedocin ST91KM and preparation of a teat seal containing the bacteriocin. Braz J Microbiol 41:133–145. https://doi.org/10.1590/S1517-838220100001000020
Raafat D, von Bargen K, Haas A, Sahl HG (2008) Insights into the mode of action of chitosan as an antibacterial compound. Appl Environ Microbiol 74:3764–3773. https://doi.org/10.1128/AEM.00453-08
Resta-Lenert S, Barrett KE (2006) Probiotics and commensals reverse TNF-alpha and IFN-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130:731–746. https://doi.org/10.1053/j.gastro.2005.12.015
Retta KS (2016) Role of probiotics in rumen fermentation and animal performance: a review. Int J Livest Prod 7(5):24–32. https://doi.org/10.5897/IJLP2016.0285
Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104(S2):S1–S63. https://doi.org/10.1017/S0007114510003363
Rokana N, Singh R, Mallappa RH, Batish VK, Grover S (2016) Modulation of intestinal barrier function to ameliorate Salmonella infection in mice by oral administration of fermented milks produced with Lactobacillus plantarum MTCC 5690–a probiotic strain of Indian gut origin. J Med Microbiol 65(12):1482–1493. https://doi.org/10.1099/jmm.0.000366
Rokana N, Mallappa RH, Batish VK, Grover S (2017) Interaction between putative probiotic Lactobacillus strains of Indian gut origin and Salmonella: impact on intestinal barrier function. LWT Food Sci Technol 84:851–860. https://doi.org/10.1016/j.lwt.2016.08.021
Rongrungruang Y, Krajangwittaya D, Pholtawornkulchai K, Tiengrim S, Thamlikitkul V (2015) Randomized controlled study of probiotics containing Lactobacillus casei (shirota strain) for prevention of ventilator-associated pneumonia. J Med Assoc Thail 98(3):253–259
Sakai F, Hosoya T, Ono-Ohmachi A, Ukibe K, Ogawa A, Moriya T, Kadooka Y, Shiozaki T, Nakagawa H, Nakayama Y, Miyazaki T (2014) Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLoS One 9:e105370. https://doi.org/10.1371/journal.pone.0105370
Sanchez M, Darimont C, Drapeau V, Emady-Azar S, Lepage M, Rezzonico E (2014) Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr 111:1507–1519. https://doi.org/10.1017/S0007114513003875
Schillinger U, Guigas C, Holzapfel WH (2005) In vitro adherence and other properties of lactobacilli used in probiotic yoghurt –like products. Int Dairy J 15:1289–1297. https://doi.org/10.1016/j.idairyj.2004.12.008
Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Aςil Y, Glüer CC, Schrezenmeir J (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137(3):838S–846S. https://doi.org/10.1093/jn/137.3.838S
Sharma R, Young C, Neu J (2010) Molecular modulation of intestinal epithelial barrier: contribution of microbiota. J Biomed Biotechnol 2010:305879. https://doi.org/10.1155/2010/305879
Sharma C, Rokana N, Chandra M, Singh BP, Gulhane RD, Gill JPS, Ray P, Puniya AK, Panwar H (2018) Antimicrobial resistance: its surveillance, impact, and alternative management strategies in dairy animals. Front Vet Sci 4:237. https://doi.org/10.3389/fvets.2017.00237
Shokryazdan P, Jahromi MF, Navidshad B, Liang JB (2017) Effects of prebiotics on immune system and cytokine expression. Med Microbiol Immunol 206(1):1–9. https://doi.org/10.1007/s00430-016-0481-y
So D, Whelan K, Rossi M, Morrison M, Holtmann G, Kelly JT, Shanahan ER, Staudacher HM, Campbell KL (2018) Dietary fiber intervention on gut microbiota composition in healthy adults: a systematic review and meta-analysis. Am J Clin Nutr 107(6):965–983. https://doi.org/10.1093/ajcn/nqy041
Sugatani J, Sadamitsu S, Wada T, Yamazaki Y, Ikari A, Miwa M (2012) Effects of dietary inulin, statin, and their co-treatment on hyperlipidemia, hepatic steatosis and changes in drug metabolizing enzymes in rats fed a high fat and high sucrose diet. Nutr Metab 9:23–41. https://doi.org/10.1186/1743-7075-9-23
Swartwout B, Luo XM (2018) Implications of probiotics on the maternal-neonatal interface: gut microbiome, immunomodulation, and autoimmunity. Front Immunol 9:2840. https://doi.org/10.3389/fimmu.2018.02840
Tannock GW, Tiong IS, Priest P, Munro K, Taylor C, Richardson A, Schultz M (2011) Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities. J Med Microbiol 60:366–370. https://doi.org/10.1099/jmm.0.025874-0
Tellez G, Laukova A, Latorre JD, Hernandez-Velasco X, Hargis BM, Callaway T (2015) Food-producing animals and their health in relation to human health. Microb Ecol Health Dis 26:25876. https://doi.org/10.3402/mehd.v26.25876
Teng PY, Kim WK (2018) Roles of prebiotics in intestinal ecosystem of broilers. Front Vet Sci 5:245. https://doi.org/10.3389/fvets.2018.00245
Thiagarajah JR, Donowitz M, Verkman AS (2015) Secretory diarrhoea: mechanisms and emerging therapies. Nat Rev Gastroenterol Hepatol 12(8):446–457. https://doi.org/10.1038/nrgastro.2015.111
Thompson AL (2019) Early gut microbiome: a good start in nutrition and growth may have lifelong lasting consequences. In: How fermented foods feed a healthy gut microbiota. Springer, Cham, pp 239–258. https://doi.org/10.1007/978-3-030-28737-5_10
Tornimbene B, Eremin S, Escher M, Griskeviciene J, Manglani S, Pessoa-Silva CL (2018) WHO global antimicrobial resistance surveillance system early implementation 2016–17. Lancet Infect Dis 18(3):241–242. https://doi.org/10.1016/S1473-3099(18)30060-4
Tsai YT, Cheng PC, Pan TM (2012) The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol 96:853–862. https://doi.org/10.1007/s00253-012-4407-3
Tuomola E, Crittenden R, Playne M, Isolauri E, Sakminen S (2001) Quality assurance criteria for probiotic bacteria. Am J Clin Nutr 73:393–398. https://doi.org/10.1093/ajcn/73.2.393s
Umu OC, Bauerl C, Oostindjer M, Pope PB, Hernández PE, Pérez-Martínez G et al (2016) The potential of class II bacteriocins to modify Gut microbiota to improve host health. PLoS One 11(10):e0164036. https://doi.org/10.1371/journal.pone.0164036
Van Baarlen P, Troost F, van der Meer C et al (2011) Human mucosal in vivo transcriptome responses to three Lactobacilli indicate how probiotics may modulate human cellular pathways. Proc Natl Acad Sci U S A 108(Suppl. 1):4562–4569. https://doi.org/10.1073/pnas.1000079107
Van de Water J, Ken CL, Gershwin ME (1999) The influence of chromic yogurt consumption on immunity. J Nutr 129:1492–1495. https://doi.org/10.1093/jn/129.7.1492S
Vanderpool C, Yan F, Polk DB (2008) Mechanisms of probiotic action: implications for therapeutic applications in inflammatory bowel diseases. Inflamm Bowel Dis 14:1585–1596. https://doi.org/10.1002/ibd.20525
Viladomiu M, Hontecillas R, Yuan L, Lu P, Bassaganya-Riera J (2013) Nutritional protective mechanisms against gut inflammation. J Nutr Biochem 24(6):929–939. https://doi.org/10.1016/j.jnutbio.2013.01.006
Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W (2012) Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol 303:G32–G41. https://doi.org/10.1152/ajpgi.00024.2012
Wang L, Cao H, Liu L, Wang B, Walker WA, Acra SA, Yan F (2014) Activation of epidermal growth factor receptor mediates mucin production stimulated by p40, a Lactobacillus rhamnosus GG derived protein. J Biol Chem 289:20234–20244. https://doi.org/10.1074/jbc.M114.553800
Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schröder JM, Stange EF (2004) NF-κB-and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72:5750–5758. https://doi.org/10.1128/IAI.72.10.5750-5758.2004
Weiss G, Rasmussen S, Zeuthen LH, Zeuthen LH, Nielsen BN, Jarmer H, Jespersen L, Frøkiær H (2010) Lactobacillus acidophilus induces virus immune defence genes in murine dendritic cells by a Toll-like receptor-2-dependent mechanism. Immunology 131:268–281. https://doi.org/10.1111/j.1365-2567.2010.03301.x
Xu L, Fan Q, Zhuang Y, Wang Q, Gao Y, Wang C (2017) Bacillus coagulans enhance the immune function of the intestinal mucosa of yellow broilers. Rev Bras Ciência Avícola 19(1):115–122. https://doi.org/10.1590/1806-9061-2015-0180
Yan F, Polk DB (2010) Probiotics: progress toward novel therapies for intestinal diseases. Curr Opin Gastroenterol 26:95–101. https://doi.org/10.1097/MOG.0b013e328335239a
Yan F, Cao H, Cover TL, Washington MK, Shi Y, Liu L, Chaturvedi R, Peek RM, Wilson KT, Polk DB (2011) Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. J Clin Invest 121:2242–2253. https://doi.org/10.1172/JCI44031
Yazawa K, Imai K, Tamura Z (1978) Oligosaccharides and polysaccharides specifically utilizableby bifidobacteria. Chem Pharm Bull 26:3306–3311. https://doi.org/10.1248/cpb.26.3306
Zanello G, Berri M, Dupont J, Sizaret PY, D’Inca R, Salmon H, Meurens F (2011) Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One 6:e18573. https://doi.org/10.1371/journal.pone.0018573
Zarepour M, Bhullar K, Montero M, Ma C, Huang T, Velcich A, Xia L, Vallance BA (2013) The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis. Infect Immun 81:3672–3683. https://doi.org/10.1128/IAI.00854-13
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Elshaghabee, F.M.F., Rokana, N. (2021). Dietary Management by Probiotics, Prebiotics and Synbiotics for the Prevention of Antimicrobial Resistance. In: Panwar, H., Sharma, C., Lichtfouse, E. (eds) Sustainable Agriculture Reviews 49. Sustainable Agriculture Reviews, vol 49. Springer, Cham. https://doi.org/10.1007/978-3-030-58259-3_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-58259-3_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58258-6
Online ISBN: 978-3-030-58259-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)